scPharmaceuticals Inc (SCPH)
4.45
+0.04
(+0.91%)
USD |
NASDAQ |
Jul 08, 09:39
scPharmaceuticals Research and Development Expense (TTM): 12.42M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.42M |
| December 31, 2023 | 11.81M |
| September 30, 2023 | 10.80M |
| June 30, 2023 | 11.09M |
| March 31, 2023 | 13.30M |
| December 31, 2022 | 15.53M |
| September 30, 2022 | 17.74M |
| June 30, 2022 | 17.71M |
| March 31, 2022 | 16.38M |
| December 31, 2021 | 16.04M |
| September 30, 2021 | 15.26M |
| June 30, 2021 | 16.68M |
| March 31, 2021 | 18.01M |
| December 31, 2020 | 18.15M |
| Date | Value |
|---|---|
| September 30, 2020 | 22.72M |
| June 30, 2020 | 21.90M |
| March 31, 2020 | 22.25M |
| December 31, 2019 | 24.63M |
| September 30, 2019 | 19.46M |
| June 30, 2019 | 19.06M |
| March 31, 2019 | 18.42M |
| December 31, 2018 | 15.95M |
| September 30, 2018 | 16.52M |
| June 30, 2018 | 16.20M |
| March 31, 2018 | 15.49M |
| December 31, 2017 | 14.33M |
| September 30, 2017 | 13.63M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
10.80M
Minimum
Sep 2023
24.63M
Maximum
Dec 2019
16.94M
Average
16.68M
Median
Jun 2021
Research and Development Expense (TTM) Benchmarks
| Vigil Neuroscience Inc | 61.43M |
| NovaBay Pharmaceuticals Inc | 0.061M |
| Palatin Technologies Inc | 25.13M |
| iBio Inc | 6.401M |
| Theriva Biologics Inc | 14.79M |